Zurn Elkay director discloses 17,844-share sale; retains 491,120 shares
Rhea-AI Filing Summary
Zurn Elkay Water Solutions director Timothy J. Jahnke reported a sale of 17,844 shares of ZWS common stock on 09/12/2025 under a Rule 10b5-1 trading plan at a weighted-average price of $47.55 per share (trades ranged $47.50–$47.60). After the sale he beneficially owns 311,120 shares directly and 180,000 shares indirectly through an irrevocable trust. The Form 4 was signed by Jeffrey J. LaValle under power of attorney for Mr. Jahnke. The filer offers to provide transaction-level share counts and prices upon request.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating prearranged trading instructions.
- Detailed disclosure of weighted-average price and offer to provide trade-level details on request.
- Substantial retained ownership: 311,120 shares direct plus 180,000 indirect via irrevocable trust.
Negative
- Reduction in direct holdings by 17,844 shares as a result of the reported sale.
- Form 4 shows an insider sale, which may be viewed negatively by some investors despite plan-based execution.
Insights
TL;DR: Director executed a prearranged sale under a 10b5-1 plan, modestly reducing direct holdings while retaining substantial ownership.
The sale of 17,844 shares at a weighted-average price of $47.55 was executed pursuant to a Rule 10b5-1 plan, which signals the trades were preplanned rather than opportunistic. Post-transaction direct beneficial ownership remains at 311,120 shares with an additional 180,000 held indirectly in an irrevocable trust, preserving significant insider alignment with shareholders. The issuer-level impact appears limited given the remaining insider stake, and full trade-level details are available on request as noted in the filing.
TL;DR: Proper disclosure and use of power of attorney; sale follows a documented 10b5-1 program.
The Form 4 discloses compliant procedures: a Rule 10b5-1 plan was used and the filing was executed under power of attorney, meeting standard governance and disclosure practices. The filing provides weighted-average sale pricing and offers to supply granular execution data, which improves transparency. There is no indication in the form of any other governance action or change in reporting status.
FAQ
What did ZWS director Timothy J. Jahnke sell on 09/12/2025?
How many ZWS shares does Timothy J. Jahnke own after the transaction?
Were the trades part of a prearranged plan?
At what prices were the shares sold?
Who signed the Form 4 filing?